Computational Scientist Salary at Broad Institute BETA

Summary The individual in this role will contribute to the advancement of neutral-atom based quantum computing technologies. The individual in this role will be involved in the design, implementation, and characterization of neutral-atom quantum computing systems, and collaborate closely with a multidisciplinary team of physicists, engineers, and computer scientists to push the boundaries of quantum computing using neutral-atom platforms. Responsibilities Design and build state-of-the-art neutral atom quantum computers. Collaborate with engineering teams to verify and validate modules and subsystems Investigate sources of noise and decoherence and propose mitigation strategies. Analyze experimental data and draw meaningful conclusions to guide system improvements. Stay current with the latest advancements in AMO physics and quantum computing. Qualifications Ph.D. or equivalent experience in Physics or a related field, with a focus on Atomic, Molecular, and Optical (AMO) physics. Hands-

Manifold Bio is a dynamic biotech company building a pipeline of targeted biologics using a novel in vivo-centric discovery approach. Our drug discovery engine is differentiated by massively parallel screening in vivo from the beginning of our discovery process. This unique platform is powered by a proprietary protein barcoding technology that allows multiplexed protein quantitation at unprecedented scale and sensitivity. We combine this and other high-throughput protein engineering approaches with computational design to create antibody-like drugs and other biologics.Our world-class team of protein engineers, biologists, and computational scientists are working together to aim the platform at therapeutic opportunities where precise targeting is the key to overcoming clinical challenges. Position Manifold Bio is seeking an experienced biotherapeutics expert to join our growing team pursuing our mission of multiplexed, in vivo drug discovery. This role will drive the protein therapeutic

Parallel Squared Technology Institute (PTI) is a non-profit research institute aiming to catalyze a leap in protein analysis technology and use it to explore new biological frontiers. PTI supports open research and educational opportunities supporting rapid career development for scientists, engineers, and mathematicians. Why? Protein dysfunctions directly cause many diseases, such as Alzheimer's disease. Yet, proteins remain understudied because of technological hurdles. How? To resolve these limitations, PTI will develop mass tags enabling a new framework for multiplexed protein analysis by mass spectrometry towards achieving 100-fold increase in throughput. Scientists at and collaborating with the institute will use these gains to directly investigate disease mechanisms and resolve problems that have proven intractable for decades. Our proof of principle technology and strategies are outlined at: parallelsq.org. New career opportunities Members of PTI will be supported with industry

About Inari... Inari is the SEEDesign™ company, using new breeding technology to push the boundaries of what is possible by designing nature-positive seeds for a more sustainable food system. A combination of AI-powered predictive design and a cutting-edge multiplex gene editing toolbox enables Inari to unlock the full potential of seed and advance critical solutions with broad applications for growing more food with fewer resources. This includes products that will generate greater yields while using significantly less land, water and other inputs. Our success is dependent on great minds, collaborating to generate bright ideas and deliver exceptional outcomes. We have over 300 employees, with research sites in Cambridge, MA (USA) and Ghent (Belgium), as well as a product development site in West Lafayette, IN (USA). We've deliberately built a team that brings diversity of thought to all aspects of our business, to generate new ideas, approaches, and ways of operating. And we've intent

Company Summary: Metaphore Biotechnologies, Inc. is a privately held biotechnology company building the next generation of biological therapeutics. Inspired by nature, our mission is to transform patient lives by unlocking the power of biological therapeutics with a new mimic-discovery platform. Flagship Pioneering is a biotechnology company that invents and builds platform companies, each with the potential for multiple products that transform human health or sustainability. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures, resulting in more than $90 billion in aggregate value. Many of the companies Flagship has founded have addressed humanity's most urgent challenges: vaccinating billions of people against COVID-19, curing intractable diseases, improving human health, preempting illness, and feeding the world by improving the resiliency and sustainability of agriculture. Flagship has been recognized twice on FORTUNE's "Change the World"

Parallel Squared Technology Institute (PTI) is a non-profit research institute aiming to catalyze a leap in protein analysis technology and use it to explore new biological frontiers. PTI supports open research and educational opportunities supporting rapid career development for scientists, engineers, and mathematicians. Why? Protein dysfunctions directly cause many diseases, such as Alzheimer's disease. Yet, proteins remain understudied because of technological hurdles. How? To resolve these limitations, PTI will develop mass tags enabling a new framework for multiplexed protein analysis by mass spectrometry towards achieving 100-fold increase in throughput. Scientists at and collaborating with the institute will use these gains to directly investigate disease mechanisms and resolve problems that have proven intractable for decades. Our proof of principle technology and strategies are outlined at: parallelsq.org. New career opportunities Members of PTI will be supported with industry

About Us Valo Health is a technology company that is integrating human-centric data and AI-powered technology to accelerate the creation of life-changing drugs for more patients faster. Valo was created with the belief that the drug discovery and development process can and should be faster and less expensive, with a much higher probability of success. We are using models early to fail less often, executing clinical trials to add valuation to the company, and generating fit-for-purpose data to feed back into Valo's Opal Computational Platform™ as we reinvent drug discovery and development from the ground up. Disease doesn't wait, so neither can we. We are a multi-disciplinary team of experts in science, technology, and pharmaceuticals united in our mission to achieve better drugs for patients faster. Valo is committed to hiring diverse talent, prioritizing growth and development, fostering an inclusive environment, and creating opportunities to bring together a group of different exper

Date Posted: 2025-01-08 Country: United States of America Location: MA105: BBN Headquarters 10 Moulton Street , Cambridge, MA, 02138 USA Position Role Type: Onsite The Raytheon BBN Networking and Cyber Technologies group seeks well-qualified and eager Formal Method researchers with System/Software Engineers experience to join exciting new projects in process logic and communications network analysis and formalism. In this position, you will pursue external funding from government research agencies (e.g. DARPA, IARPA, DoD Service Labs) to help further U.S. National Security Objectives and the betterment of society; you will attract, hire and develop top-notch talent to round out your team. This position is an opportunity to shine as a leader of an exceptional team while building technologies to support Formal Methods for verification of processes, networks, etc. You will model and analyze networks and complex processes to develop key insights and proofs, and improve understanding and pe